Corcept Therapeutics (CORT) fell ~35% in the premarket on Wednesday after the U.S. Food and Drug Administration (FDA) declined to approve
https://seekingalpha.com/news/4536026-corcept-down-fda-rejects-hormonal-therapy
Corcept Therapeutics (CORT) fell ~35% in the premarket on Wednesday after the U.S. Food and Drug Administration (FDA) declined to approve
https://seekingalpha.com/news/4536026-corcept-down-fda-rejects-hormonal-therapy
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.